Parkman Healthcare Partners LLC acquired a new position in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 59,867 shares of the company’s stock, valued at approximately $4,406,000. Parkman Healthcare Partners LLC owned about 0.10% of […]
Parkman Healthcare Partners LLC acquired a new position in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor acquired 186,272 shares of the biopharmaceutical company’s stock, valued at approximately $13,341,000. Intra-Cellular Therapies comprises about 1.9% of Parkman Healthcare Partners LLC’s portfolio, making the stock its […]
Parkman Healthcare Partners LLC decreased its position in shares of Arcellx, Inc. (NASDAQ:ACLX – Free Report) by 17.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 168,262 shares of the company’s stock after selling 35,220 shares during […]
Parkwood LLC reduced its position in JPMorgan Chase & Co. (NYSE:JPM) by 2.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 37,276 shares of the financial services provider’s stock after selling 854 shares during the period. Parkwood LLC’s holdings in JPMorgan […]
Parkman Healthcare Partners LLC acquired a new stake in Mettler-Toledo International Inc. (NYSE:MTD – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 7,500 shares of the medical instruments supplier’s stock, valued at approximately $9,097,000. Mettler-Toledo International accounts for 1.3% […]